15-Lipoxygenase Inhibition – Mitochondrial & Lipid Health

Understanding 15-Lipoxygenase

and Its Impact

15-Lipoxygenase (15-LOX) is an enzyme that plays a key role in the metabolism of polyunsaturated fatty acids. It generates bioactive lipid mediators that can promote oxidative stress and low-grade inflammation.
Elevated 15-LOX activity is associated with impaired mitochondrial function, inefficient lipid conversion, increased oxidative damage, and metabolic dysfunction. These effects can contribute to fatigue, reduced cellular energy production, cardiovascular issues, and accelerated aging processes.
Inhibiting 15-LOX helps reduce harmful lipid byproducts, protects mitochondria (the powerhouses of the cell), and supports healthier lipid metabolism and energy balance.

The Role of

15-Lipoxygenase Inhibition

By inhibiting 15-LOX, we can decrease oxidative stress on mitochondria and improve the efficient conversion and utilization of lipids.

This approach shows strong potential for:
+ Enhancing mitochondrial performance and cellular energy
+ Reducing inflammation caused by lipid metabolites
+ Supporting metabolic health and healthy aging

We believe targeted inhibition of 15-LOX represents an important strategy for improving overall cellular vitality and metabolic function.

Our Research Approach

We are focusing on one primary strategy to discover effective 15-Lipoxygenase inhibitors:

High-Throughput Screening (HTS)

for Small-Molecule Inhibitors

Using our advanced GFP-based promoter-reporter assays in human cell cultures, we screen thousands of natural and synthetic compounds to identify potent and selective inhibitors of 15-LOX gene expression and activity. This platform allows us to rapidly discover promising nutraceutical or pharmaceutical candidates that can protect mitochondria and optimize lipid metabolism.

Partnership Opportunities

We offer licensing of discovered compounds, custom research, and technology transfer for all three approaches.

HTS Screening Project: Start at $40,000 – $150,000 + 5% royalty

Gene Therapy Development: Custom pricing (typically $1M – $2M) + 5% royalty

Full technology transfer and offshore lab setup available

Head Office

Tampa
Florida, US

Call Now

312-730-2562
786-307-1256

Email Us

dr.nikolic@ufl.edu